Lupin informs about press release

28 Dec 2020 Evaluate

Lupin has informed that it has enclosed a Press Release on 28th December 2020 as regards the launch by the Company of Meloxicam Capsules, 5 mg, and 10 mg, having received an approval from the US FDA, titled ‘Lupin launches Meloxicam Capsules’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

1609.85 25.60 (1.62%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.